Phenolics-enriched extracts from Brazilian native fruits: In vitro and in vivo evaluation of the metabolism and health effects
World Congress on Pharmacology
July 20-22, 2015 Brisbane, Australia

Maria Ines Genovese

Posters-Accepted Abstracts: Clin Exp Pharmacol

Abstract:

Proanthocyanidins, flavonoids and ellagic acid derivatives are polyphenols found in high concentrations in Brazilian native fruits such as Jaboticaba (Myrciaria jaboticaba Vell. Berg), Camu-camu (Myrciaria dubia (Kunth) McVaugh) and Cupuassu (Theobroma grandiflorum (Willd. ex Spreng.) K. Schum). Those compounds are known due to their cancer chemopreventive, cardioprotective and antioxidant potential. However, little is known about their bioavailability and metabolites, which are the biologically active compounds indeed. Here, the aim is to investigate the metabolism of different classes of polyphenols present in the native fruits, and the potentially health-beneficial biological activity, in both in vitro and in vivo assays. The metabolites formed from the Jaboticaba polyphenols were identified in an in vitro fermentation model using human feces. In addition, the fate of a wide variety of metabolites was monitored after intragastric administration of Jaboticaba extract (15 min ? 8 h) in Wistar rats, using an UPLC-MS. The in vitro experiment showed that the ellagic acid derivatives were metabolized by the intestinal microbiota and degraded under testing conditions. Two compounds were identified after fermentation with fecal inoculum, p-hydroxybenzoic and p-hydroxyphenylacetic acids. In vivo, thirty eight metabolites were identified in plasma, stomach, liver, kidneys, brain, muscle and colon, and most of them were formed from ellagic acid derivatives. Further investigations were also made on the role of phenolic-rich extracts from those fruits upon oxidative stress and metabolic changes associated with a high fat (HFD) or a high-fat, high-sucrose (HFHS) diet in Wistar rats and C57BL/6J mice.